Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -1.01 is in line with its 5-year average of -1.12, near the low end of its 5-year range (-4.73–11.11).
As of the fiscal period ended Tuesday, June 30, 2026. 1.60% above its 12-month average of -1.02.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -1.01.
DEBT TO EQUITY RATIO
-1.01
DEBT TO EQUITY RATIO AVG TTM
-1.02
DEBT TO EQUITY RATIO AVG 3Y
-1.09
DEBT TO EQUITY RATIO AVG 5Y
-1.12
DEBT TO EQUITY RATIO AVG 10Y
-0.51
DEBT TO EQUITY RATIO AVG 15Y
-0.33
DEBT TO EQUITY RATIO AVG 20Y
-0.11
CURRENT VS TTM AVG
+1.60%
CURRENT VS 3Y AVG
+7.31%
CURRENT VS 5Y AVG
+9.86%
CURRENT VS 10Y AVG
-98.90%
CURRENT VS 15Y AVG
-203.59%
CURRENT VS 20Y AVG
-792.01%
SECTOR MEDIAN · HEALTHCARE
0.14
median of 513 covered companies
CURRENT VS SECTOR MEDIAN
-818.72%
vs the sector median at left
Galectin Therapeutics Inc.
Market Cap
$237.74M
Debt to Equity Ratio
-1.01
TTM Avg
-1.02
3Y Avg
-1.09
5Y Avg
-1.12
Market Cap
$235.26M
Debt to Equity Ratio
2.16
TTM Avg
6.63
3Y Avg
12.85
5Y Avg
7.19
Market Cap
$233.43M
Debt to Equity Ratio
0.01
TTM Avg
0.03
3Y Avg
0.03
5Y Avg
0.03
Market Cap
$232.88M
Debt to Equity Ratio
0.21
TTM Avg
0.17
3Y Avg
0.14
5Y Avg
0.13
Market Cap
$244.11M
Debt to Equity Ratio
N/A
TTM Avg
0.09
3Y Avg
0.09
5Y Avg
1.23
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Galectin Therapeutics Inc. (GALT) | $237.74M | -1.01 | -1.02 | -1.09 | -1.12 |
| Biodesix, Inc. (BDSX)vs › | $233.14M | 7.85 | 8.11 | 4.57 | 3.79 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.26M | 2.16 | 6.63 | 12.85 | 7.19 |
| InflaRx N.V. (IFRX)vs › | $240.09M | 0.01 | 0.01 | 0.01 | 0.01 |
| High Tide Inc. (HITI)vs › | $240.32M | 1.17 | 1.11 | 0.80 | 1.37 |
| BioAge Labs Inc. (BIOA)vs › | $233.43M | 0.01 | 0.03 | 0.03 | 0.03 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $232.88M | 0.21 | 0.17 | 0.14 | 0.13 |
| Invivyd, Inc. (IVVD)vs › | $243.85M | 0.05 | 0.01 | 0.01 | 0.01 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $244.11M | N/A | 0.09 | 0.09 | 1.23 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.12M | 9.64 | 54.87 | 37.52 | 22.91 |
Debt/Equity
-1.01
Current Ratio
0.10
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -1.01 |
| 2026-03-31 | -1.04 |
| 2025-12-31 | -1.06 |
| 2025-09-30 | -0.98 |
| 2025-06-30 | -1.03 |
| 2025-03-31 | -0.96 |
| 2024-12-31 | -1.03 |
| 2024-09-30 | -1.13 |
| 2024-06-30 | -1.14 |
| 2024-03-31 | -1.16 |
| 2023-12-31 | -1.19 |
| 2023-09-30 | -1.20 |
| 2023-06-30 | -1.18 |
| 2023-03-31 | -1.17 |
| 2022-12-31 | -1.24 |
| 2022-09-30 | -1.34 |
| 2022-06-30 | -1.95 |
| 2022-03-31 | -4.73 |
| 2021-12-31 | 11.11 |
| 2021-09-30 | 2.09 |
| 2021-06-30 | 0.57 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.00 |
| 2011-12-31 | 0.00 |
| 2011-09-30 | 0.00 |
| 2011-06-30 | 0.00 |
| 2011-03-31 | 0.00 |
| 2010-12-31 | 0.00 |
| 2010-09-30 | 0.00 |
| 2010-06-30 | 0.00 |
| 2010-03-31 | 0.00 |
| 2009-12-31 | 0.00 |
| 2009-09-30 | 0.00 |
| 2009-06-30 | 0.00 |
| 2009-03-31 | 0.00 |
| 2008-12-31 | -0.43 |
| 2008-09-30 | 0.00 |
| 2008-06-30 | 0.00 |
| 2008-03-31 | 0.00 |
| 2007-12-31 | 0.00 |
| 2007-09-30 | -0.16 |
| 2007-06-30 | 0.64 |
| 2007-03-31 | 1.21 |
| 2006-12-31 | -233.64 |
| 2006-09-30 | 501.80 |
| 2006-06-30 | -5.63 |
| 2006-03-31 | -4.12 |
| 2005-12-31 | 0.00 |
| 2005-09-30 | 0.00 |
| 2005-06-30 | 0.00 |
| 2005-03-31 | 0.00 |
| 2004-12-31 | 0.00 |
| 2004-09-30 | 0.00 |
| 2004-06-30 | 0.00 |
| 2004-03-31 | 0.00 |
| 2003-12-31 | 0.00 |
| 2003-09-30 | 0.00 |
| 2003-06-30 | 0.00 |
| 2003-03-31 | 0.01 |
| 2002-12-31 | 0.01 |
| 2002-09-30 | 0.10 |
